Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2982)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 19, 2025 (publication date) through Nov 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Pejčić AV. Targeting muscarinic receptors in schizophrenia treatment: Novel antipsychotic xanomeline/trospium chloride. World J Psychiatry 2025; 15(6): 105409 [PMID: 40574777 DOI: 10.5498/wjp.v15.i6.105409] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Pejčić AV. Targeting muscarinic receptors in schizophrenia treatment: Novel antipsychotic xanomeline/trospium chloride. World J Psychiatry 2025; 15(6): 105409 [PMID: 40574777 DOI: 10.5498/wjp.v15.i6.105409] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v15/i6/105409.htm |
| Number | Citing Articles |
| 1 |
Leslie Citrome. What’s in a name? What shall we call xanomeline-trospium combination?. Expert Opinion on Drug Safety 2025; : 1 doi: 10.1080/14740338.2025.2588631
|